BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Pivotal Therapeutics Inc.  

3701 FAU Blvd, Building 3, Suite 210

Boca Raton  Florida   33431  U.S.A.
Phone: 561-288-5231 Fax: n/a


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Pivotal Therapeutics Inc. Is To Be Featured On CEO Clips On CBC's The Documentary Channel 5/12/2015 10:06:56 AM
Pivotal Therapeutics Inc. Announces 2014 Financial Results 5/1/2015 8:21:56 AM
Pivotal Therapeutics Inc. Receives Health Canada Approval To Expand The Indication Of OMAZEN To Include Products With Claims To Maintain And Support Cardiovascular Health And Normal Triglyceride Levels 4/27/2015 11:04:35 AM
Pivotal Therapeutics Inc. Executes Memorandum Of Understanding For Exclusive Distribution Of Benefishial Line Of Products In Korea 4/16/2015 8:18:34 AM
Pivotal Therapeutics Inc. Executes Memorandum Of Understanding For Exclusive Distribution Of Benefishial Line Of Products In Korea 4/15/2015 3:14:49 PM
Pivotal Therapeutics Inc. And French University Hospital Of Strasbourg Announce POMEGA Trial Chief Investigator Dr. Yannick Georg Laureate Of EUR 30,000 French Interregional Clinical Research And Innovation Award For Investigating The Therapeutic Value Of Its Novel VASCAZEN Formulation In France 4/7/2015 12:39:01 PM
Pivotal Therapeutics Inc. Receives Notice of Allowance For U.S. Patent Related To A Kit For The Dietary Management Of Cardiovascular Patients That Includes VASCAZEN And An Omega-3 Fatty Acid Diagnostic Assay 4/2/2015 6:47:56 AM
Pivotal Therapeutics Inc. Announces Payment Of Interest On Outstanding Convertible Notes 3/26/2015 9:42:49 AM
Pivotal Therapeutics Inc. Announces The Issuance Of Two Patents Both Related To The Combination Of VASCAZENĀ® With Key Cholesterol Lowering Agents (Statins) And Cholesterol Absorption Inhibitors 2/10/2015 11:32:58 AM
Pivotal Therapeutics Inc. Receives Final Approval For Phase 2a Clinical Trial With PVT-100 1/27/2015 11:39:26 AM
1234567